7QD Stock Overview
Provides medicare advantage plans in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
Clover Health Investments, Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$3.18 |
| 52 Week High | US$4.05 |
| 52 Week Low | US$0.57 |
| Beta | 1.95 |
| 11 Month Change | -15.80% |
| 3 Month Change | 26.42% |
| 1 Year Change | 269.42% |
| 33 Year Change | -21.46% |
| 5 Year Change | n/a |
| Change since IPO | -66.14% |
Recent News & Updates
Recent updates
Shareholder Returns
| 7QD | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | -0.3% | 3.2% | 3.6% |
| 1Y | 269.4% | 18.4% | 9.0% |
Return vs Industry: 7QD exceeded the German Healthcare industry which returned 17.3% over the past year.
Return vs Market: 7QD exceeded the German Market which returned 8.6% over the past year.
Price Volatility
| 7QD volatility | |
|---|---|
| 7QD Average Weekly Movement | 12.1% |
| Healthcare Industry Average Movement | 4.3% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 11.7% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 7QD's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: 7QD's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 552 | Andrew Toy | www.cloverhealth.com/en/ |
Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat.
Clover Health Investments, Corp. Fundamentals Summary
| 7QD fundamental statistics | |
|---|---|
| Market cap | €1.62b |
| Earnings (TTM) | -€91.18m |
| Revenue (TTM) | €2.01b |
0.8x
P/S Ratio-17.8x
P/E RatioIs 7QD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 7QD income statement (TTM) | |
|---|---|
| Revenue | US$2.12b |
| Cost of Revenue | US$1.78b |
| Gross Profit | US$330.39m |
| Other Expenses | US$426.33m |
| Earnings | -US$95.94m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.19 |
| Gross Margin | 15.62% |
| Net Profit Margin | -4.54% |
| Debt/Equity Ratio | 0% |
How did 7QD perform over the long term?
See historical performance and comparison